A |
2024-07-01 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
1843.0000 |
71254.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2024-06-03 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
26193.0000 |
26193.0000 |
2 |
0001601830 |
Stock Option (Right to Buy) |
A |
2024-06-03 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
13097.0000 |
69411.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2024-04-26 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
25000.0000 |
25000.0000 |
2 |
0001745999 |
Stock Option (Right to Buy) |
A |
2024-04-26 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
12500.0000 |
82637.0000 |
1 |
0001745999 |
Common Stock |
A |
2024-04-01 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
1467.0000 |
56314.0000 |
1 |
0001601830 |
Class A Common Stock |
D |
2024-04-01 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
5446.0000 |
70137.0000 |
1 |
0001745999 |
Common Stock |
A |
2024-03-31 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
27500.0000 |
75583.0000 |
1 |
0001745999 |
Common Stock |
A |
2024-01-31 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
55000.0000 |
55000.0000 |
1 |
0001745999 |
Stock Option (Right to Buy) |
D |
2023-07-13 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
8275.0000 |
54847.0000 |
5 |
0001601830 |
Class A Common Stock |
D |
2023-07-12 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
3157.0000 |
63122.0000 |
4 |
0001601830 |
Class A Common Stock |
D |
2023-07-12 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
3195.0000 |
66279.0000 |
3 |
0001601830 |
Class A Common Stock |
D |
2023-07-12 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
78071.0000 |
69474.0000 |
2 |
0001601830 |
Class A Common Stock |
D |
2023-07-12 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
S-Sale |
--D |
24302.0000 |
147545.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2023-06-16 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
25224.0000 |
25224.0000 |
2 |
0001601830 |
Stock Option (Right to Buy) |
A |
2023-06-16 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
12612.0000 |
171847.0000 |
1 |
0001601830 |
Class A Common Stock |
D |
2023-04-04 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
2186.0000 |
47117.0000 |
2 |
0001745999 |
Common Stock |
D |
2023-04-03 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
2454.0000 |
49303.0000 |
1 |
0001745999 |
Common Stock |
A |
2023-03-31 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
20000.0000 |
51277.0000 |
1 |
0001745999 |
Common Stock |
A |
2023-01-31 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
20000.0000 |
20000.0000 |
2 |
0001745999 |
Stock Option (Right to Buy) |
A |
2023-01-31 |
|
Beam Therapeutics Inc. |
4/A |
A-Award |
--D |
40000.0000 |
40000.0000 |
1 |
0001745999 |
Stock Option (Right to Buy) |
D |
2023-01-27 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
36152.0000 |
185565.0000 |
6 |
0001745999 |
Stock Option (Right to Buy) |
D |
2023-01-27 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
36152.0000 |
31277.0000 |
4 |
0001745999 |
Common Stock |
A |
2023-01-27 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
36152.0000 |
67429.0000 |
3 |
0001745999 |
Common Stock |
D |
2023-01-26 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
1102.0000 |
221717.0000 |
5 |
0001745999 |
Stock Option (Right to Buy) |
D |
2023-01-26 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
1102.0000 |
31277.0000 |
2 |
0001745999 |
Common Stock |
A |
2023-01-26 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
1102.0000 |
32379.0000 |
1 |
0001745999 |
Common Stock |
D |
2023-01-24 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
14810.0000 |
31277.0000 |
4 |
0001745999 |
Common Stock |
A |
2023-01-24 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
14810.0000 |
46087.0000 |
3 |
0001745999 |
Common Stock |
D |
2023-01-24 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
14810.0000 |
222819.0000 |
6 |
0001745999 |
Stock Option (Right to Buy) |
D |
2023-01-23 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
5426.0000 |
237629.0000 |
5 |
0001745999 |
Stock Option (Right to Buy) |
D |
2023-01-23 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
5426.0000 |
31277.0000 |
2 |
0001745999 |
Common Stock |
A |
2023-01-23 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
5426.0000 |
36703.0000 |
1 |
0001745999 |
Common Stock |
D |
2023-01-18 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
39886.0000 |
243055.0000 |
3 |
0001745999 |
Stock Option (Right to Buy) |
D |
2023-01-18 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
47195.0000 |
31277.0000 |
2 |
0001745999 |
Common Stock |
A |
2023-01-18 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
39886.0000 |
78472.0000 |
1 |
0001745999 |
Common Stock |
A |
2023-01-03 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
1821.0000 |
159235.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2022-10-03 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
1265.0000 |
157414.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2022-07-01 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
1631.0000 |
156149.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2022-06-14 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
18145.0000 |
154518.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2022-06-14 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
36290.0000 |
36290.0000 |
2 |
0001601830 |
Stock Option (right to buy) |
A |
2022-04-01 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
1788.0000 |
136373.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2022-03-31 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
15000.0000 |
40065.0000 |
1 |
0001745999 |
Common Stock |
D |
2022-03-31 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
1787.0000 |
38278.0000 |
2 |
0001745999 |
Common Stock |
A |
2022-01-31 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
30000.0000 |
30000.0000 |
1 |
0001745999 |
Stock Option (Right to Buy) |
A |
2022-01-03 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
763.0000 |
134585.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2021-10-01 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
629.0000 |
133822.0000 |
1 |
0001601830 |
Class A Common Stock |
A |
2021-07-01 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
382.0000 |
133193.0000 |
1 |
0001601830 |
Class A Common Stock |
D |
2021-06-30 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
30000.0000 |
282941.0000 |
4 |
0001745999 |
Stock Option (Right to Buy) |
D |
2021-06-30 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
15000.0000 |
24809.0000 |
3 |
0001745999 |
Common Stock |
D |
2021-06-30 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
15000.0000 |
39809.0000 |
2 |
0001745999 |
Common Stock |
A |
2021-06-30 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
30000.0000 |
54809.0000 |
1 |
0001745999 |
Common Stock |
D |
2021-06-28 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
19800.0000 |
24809.0000 |
8 |
0001745999 |
Common Stock |
A |
2021-06-28 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
45000.0000 |
69809.0000 |
1 |
0001745999 |
Common Stock |
D |
2021-06-28 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
1100.0000 |
68709.0000 |
2 |
0001745999 |
Common Stock |
D |
2021-06-28 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
1880.0000 |
66829.0000 |
3 |
0001745999 |
Common Stock |
D |
2021-06-28 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
5220.0000 |
61609.0000 |
4 |
0001745999 |
Common Stock |
D |
2021-06-28 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
8907.0000 |
52702.0000 |
5 |
0001745999 |
Common Stock |
D |
2021-06-28 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
3290.0000 |
49412.0000 |
6 |
0001745999 |
Common Stock |
D |
2021-06-28 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
4803.0000 |
44609.0000 |
7 |
0001745999 |
Common Stock |
D |
2021-06-28 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
45000.0000 |
312941.0000 |
9 |
0001745999 |
Stock Option (Right to Buy) |
D |
2021-04-20 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
J-Other |
--D |
126561.0000 |
0.0000 |
1 |
0001601830 |
Common Stock |
D |
2021-04-20 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
C-Conversion |
--D |
6250.0000 |
0.0000 |
3 |
0001601830 |
Common Stock |
A |
2021-04-20 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
J-Other |
--D |
126561.0000 |
126561.0000 |
2 |
0001601830 |
Class A Common Stock |
A |
2021-04-20 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
C-Conversion |
--D |
6250.0000 |
132811.0000 |
4 |
0001601830 |
Class A Common Stock |
D |
2021-04-20 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
C-Conversion |
--D |
12500.0000 |
0.0000 |
5 |
0001601830 |
Stock Option (Right to Buy) |
D |
2021-04-20 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
C-Conversion |
--D |
404688.0000 |
0.0000 |
7 |
0001601830 |
Stock Option (Right to Buy) |
A |
2021-04-20 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
C-Conversion |
--D |
404688.0000 |
404688.0000 |
8 |
0001601830 |
Stock Option (Right to Buy) |
A |
2021-04-20 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
C-Conversion |
--D |
12500.0000 |
12500.0000 |
6 |
0001601830 |
Stock Option (Right to Buy) |
A |
2021-04-16 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
6250.0000 |
126561.0000 |
1 |
0001601830 |
Common Stock |
A |
2021-04-15 |
|
RECURSION PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
12500.0000 |
12500.0000 |
2 |
0001601830 |
Stock Option (Right to Buy) |
A |
2021-03-31 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
35000.0000 |
35000.0000 |
2 |
0001745999 |
Stock Option (Right to Buy) |
A |
2021-03-31 |
|
Beam Therapeutics Inc. |
4 |
A-Award |
--D |
17500.0000 |
24809.0000 |
1 |
0001745999 |
Common Stock |
A |
2021-01-04 |
|
Beam Therapeutics Inc. |
4 |
M-Exempt |
--D |
25000.0000 |
32309.0000 |
1 |
0001745999 |
Common Stock |
D |
2021-01-04 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
800.0000 |
31509.0000 |
2 |
0001745999 |
Common Stock |
D |
2021-01-04 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
1951.0000 |
29558.0000 |
3 |
0001745999 |
Common Stock |
D |
2021-01-04 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
2449.0000 |
27109.0000 |
4 |
0001745999 |
Common Stock |
D |
2021-01-04 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
6509.0000 |
20600.0000 |
5 |
0001745999 |
Common Stock |
D |
2021-01-04 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
5296.0000 |
15304.0000 |
6 |
0001745999 |
Common Stock |
D |
2021-01-04 |
|
Beam Therapeutics Inc. |
4 |
S-Sale |
--D |
7095.0000 |
8209.0000 |
7 |
0001745999 |
Common Stock |